GLOBAL BLOOD THERAPEUTICS IN (GBT) Stock Analyst Earnings Estimates
NASDAQ:GBT - Nasdaq - US37890U1088 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 2.1M | 123.8M 5,795.24% | 194.749M 57.31% | 288.826M 48.31% | 447.414M 54.91% | 638.305M 42.67% | 940.309M 47.31% | 1.399B 48.79% | |
| EBITDA YoY % growth | -280.99M -57.78% | -235.88M 16.05% | -281.781M -19.46% | -251.836M 10.63% | -125.251M 50.26% | 9.558M 107.63% | 2.714M -71.60% | 778.531K -71.32% | |
| EBIT YoY % growth | -289.6M -58.51% | -244.2M 15.68% | -287.69M -17.81% | -287.929M -0.08% | -180.17M 37.43% | -46.661M 74.10% | -71.961M -54.22% | -112.089M -55.76% | |
| Operating Margin | -13,790.48% | -197.25% | -147.72% | -99.69% | -40.27% | -7.31% | -7.65% | -8.01% | |
| EPS YoY % growth | -4.68 -37.24% | -4.03 13.89% | -4.82 -19.60% | -4.68 2.94% | -2.93 37.45% | -0.97 66.99% | -1.46 -50.71% | -2.22 -52.22% |
All data in USD
| Q3 / 22 | Q4 / 22 | Q1 / 23 | Q2 / 23 | Q3 / 23 | Q4 / 23 | Q1 / 24 | Q2 / 24 | Q3 / 24 | Q4 / 24 | Q1 / 25 | Q2 / 25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -1.13 0.29% | -1.05 22.72% | -0.98 22.35% | -0.91 27.46% | -0.84 25.71% | -0.65 38.13% | -0.22 77.29% | -0.31 65.75% | -0.41 50.53% | -0.52 20.78% | 0.16 172.73% | 0.31 200.00% |
| Revenue Q2Q % growth | 76.151M 46.30% | 85.387M 52.21% | 88.096M 59.71% | 94.91M 32.65% | 101.231M 32.93% | 116.616M 36.57% | 158.267M 79.65% | 159.075M 67.61% | 159.883M 57.94% | 160.691M 37.79% | 208.969M 32.04% | 229.977M 44.57% |
| EBITDA Q2Q % growth | -57.369M 8.77% | -52.531M 31.83% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -70.637M -4.97% | -67.527M 18.60% | -63.706M 13.04% | -59.11M 21.94% | -53.353M 24.47% | -44.528M 34.06% | N/A | N/A | N/A | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2022 Q2Q % growth | -1.26 -12.50% | -1.19 | -0.07 | -6.32% |
| Q1 2022 Q2Q % growth | -1.26 -4.13% | -1.32 | 0.06 | 4.42% |
| Q4 2021 Q2Q % growth | -1.36 -36.00% | -1.14 | -0.22 | -19.41% |
| Q3 2021 Q2Q % growth | -1.13 -16.49% | -1.13 | 0.00 | -0.39% |
| Q2 2021 Q2Q % growth | -1.12 -30.23% | -1.20 | 0.08 | 6.70% |
| Q1 2021 Q2Q % growth | -1.21 -0.83% | -1.02 | -0.19 | -18.79% |
| Q4 2020 Q2Q % growth | -1.00 42.20% | -0.95 | -0.05 | -4.92% |
| Q3 2020 Q2Q % growth | -0.97 9.35% | -0.76 | -0.21 | -26.90% |
| Q2 2020 Q2Q % growth | -0.86 14.85% | -1.16 | 0.30 | 26.07% |
| Q1 2020 Q2Q % growth | -1.20 -37.93% | -1.52 | 0.32 | 21.10% |
| Q4 2019 Q2Q % growth | -1.73 | -1.25 | -0.48 | -38.46% |
| Q3 2019 Q2Q % growth | -1.07 | -1.06 | -0.01 | -1.18% |
| Q2 2019 Q2Q % growth | -1.01 | -0.97 | -0.04 | -4.54% |
| Q1 2019 Q2Q % growth | -0.87 | -0.95 | 0.08 | 8.69% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2022 Q2Q % growth | 71.55M 50.46% | 65.376M | 6.174M | 9.44% |
| Q1 2022 Q2Q % growth | 55.16M 41.29% | 56.703M | -1.543M | -2.72% |
| Q4 2021 Q2Q % growth | 56.099M 35.83% | 55.998M | 101.116K | 0.18% |
| Q3 2021 Q2Q % growth | 52.052M 41.10% | 54.231M | -2.179M | -4.02% |
| Q2 2021 Q2Q % growth | 47.555M 50.97% | 44.362M | 3.193M | 7.20% |
| Q1 2021 Q2Q % growth | 39.04M 176.49% | 43.431M | -4.391M | -10.11% |
| Q4 2020 Q2Q % growth | 41.3M 1,857.35% | 39.421M | 1.879M | 4.77% |
| Q3 2020 Q2Q % growth | 36.89M | 43.04M | -6.15M | -14.29% |
| Q2 2020 Q2Q % growth | 31.5M | 19.221M | 12.279M | 63.89% |
| Q1 2020 Q2Q % growth | 14.12M | 4.822M | 9.298M | 192.80% |
| Q4 2019 Q2Q % growth | 2.11M | 562.843K | 1.547M | 274.88% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A |
| Revenue | N/A | N/A | N/A | N/A |